– UK, Redcar – Nuformix plc (LON: NFX), a drug re-purposing specialist, today announced the appointment of Maddy Kennedy to its Board as a Non-Executive Director effective immediately.
“It’s a pleasure for us to welcome Maddy to the Board. Maddy’s knowledge and experience will be extremely valuable as the Company moves forward with its near-term strategic priorities.” said Executive Chairman, Dr Chris Blackwell.
Maddy will be appointed as Chair of the Audit Committee.
About Maddy Kennedy
Maddy is currently CFO and Board Director of Concepta PLC and CFO of CFO4Growth Limited. She has previously acted as interim CFO for Ieso Digital Health Ltd and PsiOxus Therapeutics Ltd, was CFO for Lab21 Limited and Finance Director at Alliance Pharma plc, taking it through its IPO. She specialises in growing life science businesses and has more than 20 years’ experience in the sector, both in public and private companies.
Maddy Kennedy commented: “I am delighted to be joining the Board of Nuformix and look forward to working with the Board and the team, to achieve its strategic objectives.”
About Nuformix
Nuformix is a pharmaceutical development company focused on unlocking the therapeutic potential and value of known drugs to develop new novel medicines which provide therapeutic and commercial advantages to the currently available drug form. Nuformix’s model of repurposing drugs utilises many technologies but is focussed on its acknowledged expertise in the use of cocrystal technology through which the Group has developed and patented novel forms of small molecules. Its platform is not therapy-specific but instead has broad application across a wide range of indications. Using its technology, the Group is developing proprietary medicines for its own development pipeline and in partnership with pharmaceutical and biotech companies.
Nuformix plc shares are traded on the London Stock Exchange’s Official List under the ticker: NFX.
For more information: https://nuformix.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.